Time: 9:00 a.m. - 10:00a.m. Central Time
Join us for a Live Virtual Meeting on PF-ILD! There is no fee required to register and CME Credit is available. Visit the link below for more details.
Speaker
Kristin B. Highland, MD
Pulmonary/Critical Care Medicine
Director, Rheumatic Lung Disease Program
Cleveland Clinic
Learning Objectives
Upon completion of this activity, participants should be able to:
- Compare PF-ILD subtypes and the pathophysiology associated with the risk of progression
- Evaluate the risk of progression among patients with PF-ILD based on laboratory data
- Assess evidence from recent and ongoing clinical trials for clinical implications in the management of PF-ILD
This activity is provided by Paradigm Medical Communications, LLC.
Held in collaboration with Northwestern University and the Pulmonary Fibrosis Foundation.